Corrigendum to “Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression”
Open Access
- 7 March 2019
- journal article
- correction
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1
Abstract
[This corrects the article DOI: 10.1155/2018/2428546.].Keywords
This publication has 4 references indexed in Scilit:
- Corrigendum to “Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression”Evidence-Based Complementary and Alternative Medicine, 2019
- Toll‐Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 ExpressionEvidence-Based Complementary and Alternative Medicine, 2018
- The Polyunsaturated Fatty Acids Arachidonic Acid and Docosahexaenoic Acid Induce Mouse Dendritic Cells Maturation but Reduce T-Cell Responses In VitroPLOS ONE, 2015
- The expression of toll‐like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll‐like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cellsArthritis & Rheumatism, 2005